On March 16, 2015, the House of Representatives is scheduled to consider the following health policy legislation:

  • H.R. 284, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015 — which would require Medicare suppliers that bid under a DME, prosthetics, orthotics, and supplies (DMEPOS) competitive bidding program to submit binding bids or risk forfeiture of a surety bond;
  • H.R. 876, the “NOTICE Act” – which would require hospitals to provide certain notifications to individuals classified as being under observation status rather than admitted as inpatients;
  • H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act — to amend the Controlled Substances Act to improve the efficiency, transparency, and consistency of the Drug Enforcement Agency’s process for scheduling new drugs;
  • H.R. 647, Access to Life-Saving Trauma Care for All Americans Act — to reauthorize language from the Public Health Service Act to fund trauma care centers; and
  • H.R. 648, Trauma Systems and Regionalization of Emergency Care Reauthorization Act — to reauthorize grants supporting state and rural development of trauma systems and authorize new regionalized emergency care model pilot projects.